No Benefit Of Plasma Therapy In Reducing COVID-19 Mortality Risk: AIIMS Trial

An interim analysis of a randomised trial done at AIIMS Delhi has shown that convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, reports PTI. AIIMS Director Dr Randeep Guleria said that the trial, conducted among a group of 30 COVID-19 patients, did not show any benefit but also said that a deeper analysis will be done to see if a sub-group of COVID-19 patients may benefit from the plasma therapy.